207.51
price up icon1.42%   2.90
after-market Dopo l'orario di chiusura: 207.51
loading
Precedente Chiudi:
$204.61
Aprire:
$200.88
Volume 24 ore:
786.84K
Relative Volume:
0.62
Capitalizzazione di mercato:
$17.13B
Reddito:
$8.31B
Utile/perdita netta:
$747.89M
Rapporto P/E:
33.47
EPS:
6.2
Flusso di cassa netto:
$1.23B
1 W Prestazione:
-0.31%
1M Prestazione:
+1.89%
6M Prestazione:
-34.33%
1 anno Prestazione:
-25.73%
Intervallo 1D:
Value
$200.69
$210.05
Intervallo di 1 settimana:
Value
$200.69
$211.76
Portata 52W:
Value
$183.38
$347.72

Icon Plc Stock (ICLR) Company Profile

Name
Nome
Icon Plc
Name
Telefono
-
Name
Indirizzo
-
Name
Dipendente
42,250
Name
Cinguettio
@ICONplc
Name
Prossima data di guadagno
2024-10-23
Name
Ultimi documenti SEC
Name
ICLR's Discussions on Twitter

Confronta ICLR con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Diagnostics & Research icon
ICLR
Icon Plc
207.51 17.13B 8.31B 747.89M 1.23B 8.97
Diagnostics & Research icon
TMO
Thermo Fisher Scientific Inc
524.05 200.45B 42.37B 6.14B 7.78B 15.95
Diagnostics & Research icon
DHR
Danaher Corp
228.55 165.08B 23.74B 3.89B 4.98B 5.24
Diagnostics & Research icon
A
Agilent Technologies Inc
134.51 38.36B 6.51B 1.29B 1.37B 4.42
Diagnostics & Research icon
IQV
Iqvia Holdings Inc
197.27 35.80B 15.32B 1.41B 1.96B 7.62
Diagnostics & Research icon
IDXX
Idexx Laboratories Inc
412.26 33.76B 3.84B 866.24M 792.60M 10.37

Icon Plc Stock (ICLR) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-10-24 Downgrade Robert W. Baird Outperform → Neutral
2024-10-14 Iniziato Redburn Atlantic Neutral
2024-09-18 Iniziato Leerink Partners Outperform
2024-06-06 Iniziato Goldman Buy
2023-12-15 Iniziato Truist Buy
2023-09-13 Iniziato TD Cowen Outperform
2023-01-17 Aggiornamento Barclays Equal Weight → Overweight
2023-01-13 Aggiornamento Barclays Equal Weight → Overweight
2022-11-09 Aggiornamento BofA Securities Neutral → Buy
2022-09-07 Iniziato UBS Buy
2022-08-25 Iniziato Credit Suisse Neutral
2022-05-24 Iniziato Guggenheim Buy
2022-04-25 Downgrade Wells Fargo Overweight → Equal Weight
2022-04-12 Aggiornamento Deutsche Bank Hold → Buy
2021-09-27 Aggiornamento JP Morgan Neutral → Overweight
2021-08-05 Ripresa Credit Suisse Outperform
2021-07-23 Aggiornamento Citigroup Neutral → Buy
2021-07-14 Iniziato Citigroup Neutral
2021-04-13 Ripresa BofA Securities Neutral
2021-04-01 Aggiornamento Wells Fargo Equal Weight → Overweight
2021-03-08 Aggiornamento Robert W. Baird Neutral → Outperform
2021-03-03 Iniziato Barclays Equal Weight
2021-03-01 Aggiornamento UBS Neutral → Buy
2021-02-26 Aggiornamento Truist Hold → Buy
2020-07-24 Downgrade BofA Securities Buy → Neutral
2020-04-20 Downgrade Robert W. Baird Outperform → Neutral
2020-03-26 Aggiornamento Barclays Equal Weight → Overweight
2020-03-02 Iniziato Deutsche Bank Hold
2020-01-27 Downgrade SunTrust Buy → Hold
2020-01-08 Iniziato Wells Fargo Equal Weight
2020-01-07 Iniziato Citigroup Neutral
2019-09-23 Downgrade KeyBanc Capital Markets Overweight → Sector Weight
2019-07-26 Aggiornamento UBS Sell → Neutral
2019-01-25 Aggiornamento Mizuho Neutral → Buy
2018-10-26 Aggiornamento Evercore ISI In-line → Outperform
2018-10-09 Iniziato UBS Sell
2018-04-03 Downgrade Evercore ISI Outperform → In-line
2018-02-15 Reiterato Mizuho Neutral
2018-01-19 Iniziato Evercore ISI Outperform
2017-10-27 Reiterato Barclays Equal Weight
2017-09-11 Iniziato BofA/Merrill Buy
2017-07-31 Aggiornamento SunTrust Hold → Buy
2017-07-27 Reiterato Mizuho Neutral
2017-06-29 Aggiornamento Jefferies Hold → Buy
Mostra tutto

Icon Plc Borsa (ICLR) Ultime notizie

pulisher
Dec 19, 2024

Bioanalytical Services Market Key Players AnalysisPPD, Inc., - openPR

Dec 19, 2024
pulisher
Dec 18, 2024

ICON plc Appoints Barry Balfe as Chief Operating Officer - TipRanks

Dec 18, 2024
pulisher
Dec 18, 2024

ICON plc appoints Barry Balfe as new COO - Investing.com

Dec 18, 2024
pulisher
Dec 18, 2024

ICON Appoints 20-Year Veteran Barry Balfe as Chief Operating Officer to Drive Strategic Growth - StockTitan

Dec 18, 2024
pulisher
Dec 18, 2024

ICON's SWOT analysis: CRO giant navigates turbulent market - Investing.com

Dec 18, 2024
pulisher
Dec 17, 2024

ICON plc Announces Appointment of Barry Balfe as Chief Operating Officer - Marketscreener.com

Dec 17, 2024
pulisher
Dec 16, 2024

October 2025 Options Now Available For Icon - Nasdaq

Dec 16, 2024
pulisher
Dec 16, 2024

Contract Research Organization Services Market Set to Witness Significant Growth by 2024-2031: IQVIA, LabCorp, - EIN News

Dec 16, 2024
pulisher
Dec 11, 2024

ICON's SWOT analysis: cro stock navigates challenges amid industry shifts - Investing.com

Dec 11, 2024
pulisher
Dec 11, 2024

Preclinical Assets Market CAGR of 7.5% Size, Share, Trends, Future Prospect By 2024-2031 | Eurofins - EIN News

Dec 11, 2024
pulisher
Dec 11, 2024

Biomarker Research Services Market Set to Witness Significant Growth by 2024-2031:Reprocell Corporation, - EIN News

Dec 11, 2024
pulisher
Dec 09, 2024

ICON Public Limited Company (ICLR) Fell on Reduced Guidance - Insider Monkey

Dec 09, 2024
pulisher
Dec 09, 2024

Virtual Clinical Trials Market Key Players AnalysisICON, plc; Parexel International Corporation; IQVIA; Covance. - openPR

Dec 09, 2024
pulisher
Dec 05, 2024

ICON Survey Highlights Sustained Investment in AI and Digital R&D Innovation, Tempered by Siloed Adoption - sharewise

Dec 05, 2024
pulisher
Dec 05, 2024

ICON Survey: 82% of Pharma Leaders See AI Boosting R&D Returns as Digital Investment Surges 34% - StockTitan

Dec 05, 2024
pulisher
Dec 04, 2024

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of ICON Public Limited Company (ICLR) on Behalf of Investors - GlobeNewswire Inc.

Dec 04, 2024
pulisher
Nov 29, 2024

Top 30 IQVIA Competitors & Alternatives in [year] - Marketing91

Nov 29, 2024
pulisher
Nov 22, 2024

Icon PLC (ICLR) Down 4.1% Since Last Earnings Report: Can It Rebound? - Yahoo Finance

Nov 22, 2024
pulisher
Nov 21, 2024

Should You Retain Your Conviction in Icon Plc (ICLR)? - Yahoo Finance

Nov 21, 2024
pulisher
Nov 20, 2024

ICON stock labeled a "Fresh Pick" as Baird bets on recovery at current valuation - Investing.com

Nov 20, 2024
pulisher
Nov 18, 2024

Pharmacovigilance and Drug Safety Software Market Skyrockets to $359.30 Million by 2031 Dominated by Tech GiantsArisEurope, ICON plc and Syneos Health | The Insight Partners - GlobeNewswire

Nov 18, 2024
pulisher
Nov 17, 2024

Redburn Atlantic Initiates Coverage of ICON Public Limited (ICLR) with Neutral Recommendation - MSN

Nov 17, 2024
pulisher
Nov 17, 2024

ICON Public Limited (NASDAQ:ICLR) Shares Sold by Entropy Technologies LP - MarketBeat

Nov 17, 2024
pulisher
Nov 14, 2024

Prudential expands preferred healthcare network in partnership with Icon Cancer Centre - Media OutReach

Nov 14, 2024
pulisher
Nov 13, 2024

ICON Plc stock hits 52-week low at $208.38 amid market shifts - Investing.com India

Nov 13, 2024
pulisher
Nov 13, 2024

ICON to Present at London Healthcare Conference - TipRanks

Nov 13, 2024
pulisher
Nov 13, 2024

ICON plc to Present at the Jefferies London Healthcare Conference - Business Wire

Nov 13, 2024
pulisher
Nov 12, 2024

Icon Plc (ICLR-Q) QuotePress Release - The Globe and Mail

Nov 12, 2024
pulisher
Nov 11, 2024

Rose Kidd, ICON – Winner of WMB Businesswoman Award 2024 - Women Mean Business

Nov 11, 2024
pulisher
Nov 06, 2024

Icon PLC (ICLR) Shares Up 3.48% on Nov 6 - GuruFocus.com

Nov 06, 2024
pulisher
Nov 05, 2024

Life Sciences BPO Market Set to Witness Significant Growth by 2024-2031:Catalent, Inc., Covance, Inc., Fareva, - EIN News

Nov 05, 2024
pulisher
Nov 05, 2024

Contract Research Organization Services Market Business - openPR

Nov 05, 2024
pulisher
Nov 05, 2024

Icon (FRA:IJF) GF Value Rank : 10 (As of Nov. 04, 2024) - GuruFocus.com

Nov 05, 2024
pulisher
Nov 02, 2024

ICON Plc stock touches 52-week low at $219.87 amid market shifts - Investing.com Australia

Nov 02, 2024
pulisher
Oct 30, 2024

Icon PLC (ICLR) Trading 3.72% Higher on Oct 2 - GuruFocus.com

Oct 30, 2024
pulisher
Oct 28, 2024

ICLR Misses on Q3 Earnings, Lowers 2024 Guidance, Stock Falls - Yahoo Finance

Oct 28, 2024
pulisher
Oct 25, 2024

ICON's $650 Million Power Play: Can This Bold Move Reverse a 21% Stock Plunge? - Yahoo Finance UK

Oct 25, 2024
pulisher
Oct 25, 2024

ICON perks up after $250M share buyback - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

Baird Downgrades ICON Public Limited (ICLR) - MSN

Oct 25, 2024
pulisher
Oct 25, 2024

Icon plc Strengthens Investor Confidence with Secured Notes - TipRanks

Oct 25, 2024
pulisher
Oct 25, 2024

Earnings call: ICON PLC faces headwinds, eyes strategic growth By Investing.com - Investing.com Australia

Oct 25, 2024
pulisher
Oct 25, 2024

Earnings call: ICON PLC faces headwinds, eyes strategic growth - Investing.com India

Oct 25, 2024
pulisher
Oct 25, 2024

Icon Earnings: Shares Tank as Elevated Cancellations Reduce 2024 Guidance - Morningstar

Oct 25, 2024
pulisher
Oct 25, 2024

Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Challenges with Strategic ... - Yahoo Finance

Oct 25, 2024
pulisher
Oct 25, 2024

ICON Public Limited Company (NASDAQ:ICLR) Q3 2024 Earnings Call Transcript - Insider Monkey

Oct 25, 2024
pulisher
Oct 25, 2024

Pharmaceutical Contract Sales Outsourcing (CSO) Market Projected To Witness Substantial Growth, 2024-2031: - EIN News

Oct 25, 2024
pulisher
Oct 25, 2024

Icon PLC (ICLR) Q3 2024 Earnings Call Highlights: Navigating Cha - GuruFocus.com

Oct 25, 2024
pulisher
Oct 24, 2024

ICON Plc stock touches 52-week low at $227.56 amid market shifts - Investing.com Australia

Oct 24, 2024
pulisher
Oct 24, 2024

U.S. Markets Finished Mixed Thursday As Tesla Led, Icon PLC Lagged - Barron's

Oct 24, 2024
pulisher
Oct 24, 2024

ICON stock slips after guidance cut (ICLR:NASDAQ) - Seeking Alpha

Oct 24, 2024
pulisher
Oct 24, 2024

Icon PLC Down Over 19%, on Pace for Largest Percent Decrease Since March 1999 — Data Talk - Morningstar

Oct 24, 2024

Icon Plc Azioni (ICLR) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
diagnostics_research LH
$228.61
price up icon 0.72%
$161.88
price up icon 2.40%
$136.02
price up icon 1.51%
diagnostics_research WAT
$368.16
price up icon 2.09%
diagnostics_research MTD
$1,230.74
price up icon 2.05%
$412.26
price up icon 0.79%
Capitalizzazione:     |  Volume (24 ore):